Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Apr 27, 2012

NEW YORK (GenomeWeb News) – Pacific Biosciences said this week that Karen Bray has joined the company as VP of North American Sales. Bray previously was a sequencing sales leader at Life Technologies selling Ion Torrent and SOLiD systems in the Southeast and Mid-Atlantic regions, and before that she held sales posts at Beckman Coulter, Fisher Scientific, and Whatman.

In addition, Martha Trela, Pacific Biosciences' former vice president of marketing, has left the company and currently works as an industry consultant. Previously, she was vice president of commercial marketing at Affymetrix and vice president of worldwide marketing at Applied Biosystems (now part of Life Technologies).


Real Time Genomics has appointed Steve Lombardi to be company president and CEO, the genomic analysis software company said this week. Lombardi was president and then CEO of Helicos Biosciences between 2006 and 2010, and he was a senior executive involved in corporate development and business management at Affymetrix between 2002 and 2006. He also held several sales and management positions at Applied Biosystems in product, sales, and business management from 1986 to 2002.


PerkinElmer said in a filing with the US Securities and Exchange Commission this week that it has re-elected its board of directors to serve a one-year term. The directors include Peter Barrett; Robert Friel; Nicholas Lopardo; Alexis Michas; James Mullen; Vicki Sato; Kenton Sicchitano; and Patrick Sullivan. Friel is chairman and CEO of the company.


Life Technologies said this week in an SEC filing that William Longfield has retired from the board of directors, and that shareholders have re-elected Donald Grimm, Ora Pescovitz, and Per Peterson to remain on the board.


Bio-Rad Laboratories' shareholders have re-elected several members of the board of directors including President and CEO Norman Schwartz, Alice Schwartz, Ted Love, Albert Hillman, and Louis Drapeau.


Pathway Genomics said this week that it has named new members to its scientific advisory board, including, James Fowler, Christoph Lange, and Nicholas Schork, and it has named Lixin Zhou to lead its internal computational and bioinformatics team.

Fowler is a professor of medical genetics at the University of California, San Diego School of Medicine who is known for research in behavioral genetics and social networking, behavioral economics, and political behavior. Lange is an assistant professor at Harvard Medical School and an associate professor of biostatistics at the Harvard School of Public Health, and his research centers on statistical genetics and generalized linear models. Schork is a professor of molecular and experimental medicine and director of bioinformatics and biostatistics at the Scripps Research Institute, and his research focuses on quantitative human genetics and integrated approaches to complex biological and medical problems.

Zhou formerly was a senior scientist at Illumina and a collaborative bioinformatics investigator at The Institute for Genomic Research.


SeraCare Life Sciences said this week that it has named Charlie Mamrak to be company CEO and Harold Ingalls as CFO. The company also has appointed former Millipore CEO Fran Lunger to chair its board and Bill Drehkoff and Brian Miller of Linden, LLC to serve on the board. Mamrak previously was CEO of PML Microbiologicals and Ingalls formerly was president and CEO of ArunA Biomedical and CFO of Premier Exhibitions and CardioMems.


Trovagene has named Keith McCormick to be head of commercial operations. McCormick recently was senior director of sales operations at bioTheranostics and he was an executive at AviaraDx, now called BioTheranostics, where he built the firm's commercial sales and marketing organization. McCormick also held posts at Schering Plough, Biogen, and Dianon Systems.


Vermillion has nominated Paul Sohmer to stand for election to its board of directors at the upcoming board meeting. Sohmer is currently CEO of Viracor-IBT Laboratories, and he formerly was CEO of Pathway Diagnostics, Orthocon, and Cylex, and he was chairman of Molecular Biometrics. He also was CEO, chairman, and president at TriPath Imaging and Neuromedical Systems, which was acquired by Tripath.


HTG Molecular Diagnostics has hired Chris Roberts to be VP of Medical Innovation. Roberts formerly was VP of the oncology division at Caris Life Sciences and he was a director in Ventana Medical Systems' molecular diagnostic and strategic marketing divisions.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.